| ACORAMIDIS HYDROCHLORIDE | None | ||
| 356MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ATTRUBY is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascularrelated hospitalization. | |||
|
Yes
| |||
| ATTRUBY | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||
| ************** ** *********** ** ********** ******** | ********* *** ************ **** **** *** ********* ************* *** ***** *** *** ********** ************* *********** *** *******-******* ************ | ********* *** ************ **** **** *** ********* ************* *** ***** *** *** ********** ************* *********** *** *******-******* ************ | ********* *** ************ **** **** *** ********* ************* *** ***** *** *** ********** ************* *********** *** *******-******* ************ | ********* *** ************ **** **** *** ********* ************* *** ***** *** *** ********** ************* *********** *** *******-******* ************ | ******* *** ********* **-**, *** *************, *** ***** ******* | ********* *** ************ **** **** *** ********* ************* *** ***** *** *** ********** ************* *********** *** *******-******* ************ | ******* ** ******** *** *********** ***** **** | ************ ** **** | ********* *** ********* **-**, *** *************, *** ***** ******* | ************ ** **** | ******* ** ******** *** *********** ***** **** | ************ ** **** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|